A detailed history of Meeder Advisory Services, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Meeder Advisory Services, Inc. holds 12,508 shares of DNA stock, worth $104,191. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,508
Previous 11,098 12.7%
Holding current value
$104,191
Previous $12.9 Million 67.52%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$0.28 - $1.16 $394 - $1,635
1,410 Added 12.7%
12,508 $4.18 Million
Q1 2024

May 07, 2024

BUY
$1.06 - $1.67 $11,763 - $18,533
11,098 New
11,098 $12.9 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.7B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Meeder Advisory Services, Inc. Portfolio

Follow Meeder Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meeder Advisory Services, Inc. with notifications on news.